[1]Timmins GS, Deretic V. Mechanisms of action of isoniazid. Mol Microbiol, 2006, 62: (5):1220-1227. [2]Ranguelova K, Suarez J, Magliozzo RS, et al. Spin trapping investigation of peroxide- and isoniazid-induced radicals in Mycobacterium tuberculosis catalase-peroxidase. Biochemistry, 2008, 47(43):11377-11385. [3]刘宇红, 姜广路, 赵立平, 等. 第四次全国结核病流行病学抽样调查——结核分枝杆菌耐药性分析与评价.中华结核和呼吸杂志, 2002, 25(4): 224-227. [4]Kruczak K, Nizankowska-Mogilnicka E. Multidrug resistance tuberculosis-current problems. Pneumonol Alergol Pol, 2009,77(3):276-283. [5]Jenkins HE, Zignol M, Cohen T. Quantifying the burden and trends of isoniazid resistant tuberculosis, 1994—2009. PLoS One, 2011, 6(7):e22927. [6]Bostanabad SZ, Nojoumi SA, Jabbarzadeh E, et al. High level isoniazid resistance correlates with multiple mutation in the katG encoding catalase proxidase of pulmonary tuberculosis isolates from the frontier localities of Iran. Tuberk Toraks, 2011,59(1):27-35. [7]Cade CE, Dlouhy AC, Medzihradszky KF, et al. Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities. Protein Sci, 2010,19(3):458-474. [8]Ho YM, Sun YJ, Wong SY, et al. Contribution of dfrA and inhA mutations to the detection of isoniazid-resistant Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother, 2009,53(9):4010-4012. [9]Sun YJ, Lee AS, Wong SY, et al. Analysis of the role of Mycobacterium tuberculosis kasA gene mutations in isoniazid resis-tance. Clin Microbiol Infect, 2007,13(8):833-835. [10]Cardoso RF, Cardoso MA, Leite CQ, et al. Characterization of ndh gene of isoniazid resistant and susceptible Mycobacte-rium tuberculosis isolates from Brazil. Mem Inst Oswaldo Cruz, 2007,102(1):59-61. [11]Dalla Costa ER, Ribeiro MO, Silva MS, et al. Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America. BMC Microbiol, 2009, 9:39. [12]Khosravi AD, Goodarzi H, Alavi SM. Detection of genomic mutations in katG, inhA and rpoB genes of Mycobacterium tuberculosis isolates using polymerase chain reaction and multiplex allele-specific polymerase chain reaction. Braz J Infect Dis, 2012, 16(1):57-62. [13]虞忻, 沈兴华, 唐佩军, 等. 苏州市结核病耐多药情况分析. 临床肺科杂志, 2012, 17(2): 269-270. [14]王胜芬,赵冰,宋媛媛,等.我国耐药结核病的危险因素——2007年全国结核病耐药基线调查资料分析.中国防痨杂志,2013,35(4):221-226. [15]De Rossi E, Aínsa JA, Riccardi G. Role of mycobacterial efflux transporters in drug resistance: an unresolved question. FEMS Microbiol Rev, 2006, 30(1): 36-52. [16]Danilchanka O, Mailaender C, Niederweis M. Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis. Antimicrob Agents Chemother, 2008, 52(7):2503-2511. |